These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 39025344)

  • 1. m6A epitranscriptomic and epigenetic crosstalk in liver fibrosis: Special emphasis on DNA methylation and non-coding RNAs.
    Dong QQ; Yang Y; Tao H; Lu C; Yang JJ
    Cell Signal; 2024 Oct; 122():111302. PubMed ID: 39025344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m6A epitranscriptomic and epigenetic crosstalk in cardiac fibrosis.
    Liu ZY; Lin LC; Liu ZY; Yang JJ; Tao H
    Mol Ther; 2024 Apr; 32(4):878-889. PubMed ID: 38311850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the epitranscriptomic role of N
    Ogbe SE; Wang J; Shi Y; Wang Y; Xu Z; Abankwa JK; Dal Pozzo L; Zhao S; Zhou H; Peng Y; Chu X; Wang X; Bian Y
    Biomed Pharmacother; 2024 Aug; 177():117041. PubMed ID: 38964182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery.
    Bian EB; Zhao B; Huang C; Wang H; Meng XM; Wu BM; Ma TT; Zhang L; Lv XW; Li J
    Cell Signal; 2013 Sep; 25(9):1837-44. PubMed ID: 23707524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing.
    Wen T; Li T; Xu Y; Zhang Y; Pan H; Wang Y
    Cell Commun Signal; 2023 Dec; 21(1):355. PubMed ID: 38102645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology.
    Malovic E; Ealy A; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2021 Apr; 181(1):13-22. PubMed ID: 33616673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
    Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
    Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation in fibrosis progress.
    Xue T; Qiu X; Liu H; Gan C; Tan Z; Xie Y; Wang Y; Ye T
    Pharmacol Res; 2021 Nov; 173():105910. PubMed ID: 34562602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome-wide analysis of N6-methyladenosine uncovers its regulatory role in gene expression in the lepidopteran Bombyx mori.
    Li B; Wang X; Li Z; Lu C; Zhang Q; Chang L; Li W; Cheng T; Xia Q; Zhao P
    Insect Mol Biol; 2019 Oct; 28(5):703-715. PubMed ID: 30957943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of hepatic stellate cell activation and liver fibrosis.
    El Taghdouini A; van Grunsven LA
    Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1397-1408. PubMed ID: 27762150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of liver fibrosis.
    Page A; Mann DA
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S64-8. PubMed ID: 26189981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crosstalk between m
    Zhao Y; Chen Y; Jin M; Wang J
    Theranostics; 2021; 11(9):4549-4566. PubMed ID: 33754077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
    Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial quality control in liver fibrosis: Epigenetic hallmarks and therapeutic strategies.
    Jia L; Yang Y; Sun F; Tao H; Lu C; Yang JJ
    Cell Signal; 2024 Mar; 115():111035. PubMed ID: 38182067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitranscriptomic Regulations in the Heart.
    Benak D; Kolar F; Hlavackova M
    Physiol Res; 2024 Apr; 73(Suppl 1):S185-S198. PubMed ID: 38634649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic analysis of m6A methylation spectroscopy during progression and reversal of hepatic fibrosis.
    Cui Z; Huang N; Liu L; Li X; Li G; Chen Y; Wu Q; Zhang J; Long S; Wang M; Sun F; Shi Y; Pan Q
    Epigenomics; 2020 Oct; 12(19):1707-1723. PubMed ID: 33174480
    [No Abstract]   [Full Text] [Related]  

  • 17. Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types.
    Shen S; Zhang R; Jiang Y; Li Y; Lin L; Liu Z; Zhao Y; Shen H; Hu Z; Wei Y; Chen F
    Mol Cancer; 2021 Apr; 20(1):67. PubMed ID: 33849552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.
    Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K
    Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
    Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
    RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics in Liver Fibrosis.
    Massey V; Cabezas J; Bataller R
    Semin Liver Dis; 2017 Aug; 37(3):219-230. PubMed ID: 28847033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.